Table 3.

Changes in cell-cycle distribution of K562 cells induced by MVs generated under different conditions of stimulation



PHA

PMA

PHA + act D

G0/G1
S
G2/M
G0/G1
S
G2/M
G0/G1
S
G2/M
Control cells   52.7 ± 0.6   23.6 ± 2.1   13.9 ± 0.7   53.1 ± 0.3   24.1 ± 0.7   12.7 ± 1.4   52.5 ± 0.9   23.8 ± 1.4   13.8 ± 0.5  
MV, 5 μg/mL   53.6 ± 1.4   24.7 ± 0.9   13.1 ± 0.9   54.06 ± 1.8   24.4 ± 1.1   12.4 ± 1.1   ND   ND   ND  
MV, 10 μg/mL   53.8 ± 0.5   24.6 ± 2.7   12.8 ± 0.9   53.9 ± 0.3   23.9 ± 0.3   12.7 ± 1.2   64.9 ± 1.9*  13.71 ± 1.1*  11.6 ± 0.9* 
MV + @Smo   ND   ND   ND   ND   ND   ND   63.7 ± 2.8*  16.1 ± 0.7*  12.8 ± 0.9* 
MV + @control
 
ND
 
ND
 
ND
 
ND
 
ND
 
ND
 
62.3 ± 3.3*
 
17.3 ± 0.6*
 
19.02 ± 1.1*
 


PHA

PMA

PHA + act D

G0/G1
S
G2/M
G0/G1
S
G2/M
G0/G1
S
G2/M
Control cells   52.7 ± 0.6   23.6 ± 2.1   13.9 ± 0.7   53.1 ± 0.3   24.1 ± 0.7   12.7 ± 1.4   52.5 ± 0.9   23.8 ± 1.4   13.8 ± 0.5  
MV, 5 μg/mL   53.6 ± 1.4   24.7 ± 0.9   13.1 ± 0.9   54.06 ± 1.8   24.4 ± 1.1   12.4 ± 1.1   ND   ND   ND  
MV, 10 μg/mL   53.8 ± 0.5   24.6 ± 2.7   12.8 ± 0.9   53.9 ± 0.3   23.9 ± 0.3   12.7 ± 1.2   64.9 ± 1.9*  13.71 ± 1.1*  11.6 ± 0.9* 
MV + @Smo   ND   ND   ND   ND   ND   ND   63.7 ± 2.8*  16.1 ± 0.7*  12.8 ± 0.9* 
MV + @control
 
ND
 
ND
 
ND
 
ND
 
ND
 
ND
 
62.3 ± 3.3*
 
17.3 ± 0.6*
 
19.02 ± 1.1*
 

MVs were obtained from CEM T cells treated with either medium (control cells), PHA (MVHh-), PMA (MVHh-), or PHA/act D (MVHh+) and added at the indicated concentrations to K562-cell cultures. In parallel, K562 cells treated with PHA/act D-generated MV (MVHh+) were also incubated with anti-Smo (@Smo, 1:150) or preimmune sera (@control, 1:150).

Data are from 7 experiments.

*

P < .05, significantly different from control cells.

or Create an Account

Close Modal
Close Modal